Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Mar;16(3):455-63.
doi: 10.3201/eid1603.090290.

Invasive Haemophilus influenzae Disease, Europe, 1996-2006

Shamez Ladhani  1 , Mary P E Slack, Paul T Heath, Anne von Gottberg, Manosree Chandra, Mary E Ramsay; European Union Invasive Bacterial Infection Surveillance participants
Collaborators, Affiliations

Invasive Haemophilus influenzae Disease, Europe, 1996-2006

Shamez Ladhani et al. Emerg Infect Dis. 2010 Mar.

Abstract

An international collaboration was established in 1996 to monitor the impact of routine Haemophilus influenzae type b (Hib) vaccination on invasive H. influenzae disease; 14 countries routinely serotype all clinical isolates. Of the 10,081 invasive H. influenzae infections reported during 1996-2006, 4,466 (44%, incidence 0.28 infections/100,000 population) were due to noncapsulated H. influenzae (ncHi); 2,836 (28%, 0.15/100,000), to Hib; and 690 (7%, 0.036/100,000), to non-b encapsulated H. influenzae. Invasive ncHi infections occurred in older persons more often than Hib (median age 58 years vs. 5 years, p<0.0001) and were associated with higher case-fatality ratios (12% vs. 4%, p<0.0001), particularly in infants (17% vs. 3%, p<0.0001). Among non-b encapsulated H. influenzae, types f (72%) and e (21%) were responsible for almost all cases; the overall case-fatality rate was 9%. Thus, the incidence of invasive non-type b H. influenzae is now higher than that of Hib and is associated with higher case fatality.

PubMed Disclaimer

Figures

Figure
Figure
Age-specific incidence for disease caused by Haemophilus influenzae type b (Hib) and noncapsulated H. influenzae (ncHi) for all countries combined, Europe, 2000–2006. A) All age groups; B) infants <1 year of age.
See this image and copyright information in PMC

References

    1. Pittman M. Variation and type specificity in the bacterial species Haemophilus influenzae. J Exp Med. 1931;53:471–92. 10.1084/jem.53.4.471 - DOI - PMC - PubMed
    1. Peltola H. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin Microbiol Rev. 2000;13:302–17. 10.1128/CMR.13.2.302-317.2000 - DOI - PMC - PubMed
    1. Heath PT, Booy R, Azzopardi HJ, Slack MP, Fogarty J, Moloney AC, et al. Non–type b Haemophilus influenzae disease: clinical and epidemiologic characteristics in the Haemophilus influenzae type b vaccine era. Pediatr Infect Dis J. 2001;20:300–5. 10.1097/00006454-200103000-00016 - DOI - PubMed
    1. Cardines R, Giufre M, Mastrantonio P, Ciofi Degli Atti ML, Cerquetti M. Nontypeable Haemophilus influenzae meningitis in children: phenotypic and genotypic characterization of isolates. Pediatr Infect Dis J. 2007;26:577–82. 10.1097/INF.0b013e3180616715 - DOI - PubMed
    1. O’Neill JM, St Geme JW III, Cutter D, Adderson EE, Anyanwu J, Jacobs RF, et al. Invasive disease due to nontypeable Haemophilus influenzae among children in Arkansas. J Clin Microbiol. 2003;41:3064–9. 10.1128/JCM.41.7.3064-3069.2003 - DOI - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources